Search results
Gateway - The Root
The Root· 23 hours agoThe Biden administration is expected to announce this week that Americans who got the Pfizer-BioNTech or Moderna vaccines will need the third shot to protect themselves against ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days ago"We are interested in seeing how effective Sanofi FP is at raising consumer awareness of Novavax's...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 10 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 5 days agoPer Zambrano, all three COVID vaccine manufacturers—Pfizer, Moderna, and Novavax—have said that...
7 Struggling Stocks to Sell Before July 2024
InvestorPlace via Yahoo Finance· 6 days agoThe stock market’s surge continues, with several major market indices making new all-time highs recently. The explosion of artificial intelligence and...
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 3 days agoCombination vaccines have been successfully used for several decades in Australia and around the...
Gateway - Quartz
Quartz· 24 hours agoLike many other wealthy nations, the country bought many more vaccines than it needed—a total of nearly 32 million—to account for potential quality issues, or supply delays. This week, the nation ...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 6 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
